Business Wire

Alps Electric to Exhibit at Major Chinese Trade Show ELEXCON 2017

Del

Japanese electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (President: Toshihiro Kuriyama; Head Office: Tokyo) will exhibit at ELEXCON 2017, to be held at the Shenzhen Convention & Exhibition Center in Shenzhen, China, from December 21. The company will introduce a wide range of technologies, particularly in the Internet of Things (IoT) domain.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171213005033/en/

Alps Electric Booth Design (Graphic: Business Wire)

Alps Electric Booth Design (Graphic: Business Wire)

At ELEXCON 2017, one of China’s largest electronics expositions, Alps Electric will showcase technologies and solutions targeting each of the Internet of Things (IoT), Mobile and Automotive markets.

Exhibit Highlight: IoT Sensor Network Module

A sensor module for collecting a variety of data, essential for IoT business creation. Integrating low-power, high-precision and compact sensors with a Bluetooth® communication module, the product is capable of acquiring pressure, temperature, humidity, ambient light and other environmental data, as well as six-axis (geomagnetism + acceleration) sensing.

A special app (for Android) is available for viewing data on a smartphone or tablet and for changing settings. In addition, radio certification has already been acquired for various regions around the world, allowing smooth, low-cost progression to demonstration testing.

At ELEXCON 2017, we will present actual application examples in areas including abnormality detection in factory facilities and agricultural ICT.

Other exhibits include the HAPTIC™ Reactor, which uses vibrations with outstanding responsiveness to realistically recreate the feel of objects in virtual reality; the compact, ink-free Inkless Mobile Printer ideal for carrying around; and V2X (Vehicle-to-X) Communication Modules, which Alps Electric started mass-producing before the rest of the industry. These products have all performed well on the market.

If you are at ELEXCON 2017, please stop by the Alps Electric booth.

Outline of the Exhibition

Exhibition:   ELEXCON 2017
Dates: December 21-23, 2017
Venue: Shenzhen Convention & Exhibition Center
Booth location: Hall 1 IC/Electronic Components Area
 

Exhibits

• IoT Sensor Network Module
• HAPTIC™ Reactor
• Spring Contacts
• Geomagnetic Sensors
• TACT Switch™
• Inkless Mobile Printer
• Brake Pedal Sensor
• V2X Communication Modules for Automotive Use and more…

Alps Electric Core Technologies

Alps Electric possesses core technologies in three areas—human-machine interfaces, sensors and connectivity—and persistently creates electronic components of value for the customer through enrichment and fusion of those technologies.

The company has performed tremendously well in these areas. In the human-machine interface and sensor domains, Alps Electric has been selected as primary supplier of products for applications including smartphones, game consoles and automobiles. And in the connectivity domain, the company led the industry in commencing mass production of V2X modules for vehicle-to-vehicle and vehicle-to-infrastructure communication.

Efforts of Alps Electric in the Chinese Market

Alps Electric embarked on business in China in 1984, initially engaging in plant exports for color TV components. Operations in China were expanded in keeping with the company philosophy of setting down roots and contributing to the local electronics industry. Alps Electric currently has six manufacturing, three R&D and seven sales bases in Beijing, Shanghai, Dalian, Tianjin and elsewhere.

About Alps Electric

Company name: Alps Electric Co., Ltd.
Date of establishment: November 1, 1948
Registered capital:38 billion 730 million yen (as of March 31, 2017)
Number of employees: 42,053 people (Alps Group as of March 31, 2017)
Number of employees: 5,588 people (Alps Electric Co., Ltd. as of March 31, 2017)
Net revenue: 753 billion 262 million yen (Alps Group as of March 2017)
Net revenue: 374 billion 382 million yen (Alps Electric Co., Ltd. as of March 2017)

Contact information

Inquiries About This Press Release
Alps Electric Co., Ltd.,
Asagi Tsukahara, +81-3-5499-8001
Public Relations Team
Corporate Planning Office
asagi.tsukahara@jp.alps.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F24.4.2018 20:30Pressemelding

Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases based on its proprietary ERYCAPS platform, encapsulating therapeutic drug substances inside red blood cells, today announced that it had filed its 2017 “Document de Référence” for the year ended December 31, 2017, including the management report and the annual financial report with the “Autorité des Marchés Financiers (AMF)” and its Annual Report on Form 20-F for the year ended December 31, 2017 with the U.S. Securities and Exchange Commission (SEC). These documents can be accessed on the Investors section of the Company’s corporate website (www.erytech.com). In addition, the “Document de Référence” is also available on the AMF’s website (http://www.amf-france.org) and the Annual Report on Form 20-F is also available on the SEC’s website (www.sec.gov). Printed copies of these documents are also

Rimini Street Launches New Solutions that Further Extend the Life and Value of Enterprise Software as a Foundation for Innovation24.4.2018 16:00Pressemelding

Rimini Street, Inc . (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced the first offerings in a family of solutions designed to provide improved competitive advantage to organizations with mature and valuable enterprise software investments that can be used as a foundation for innovation. Rimini Street’s new solutions can enable an organization to quickly and cost-effectively modernize their current enterprise software with the latest desired features and capabilities, future-proof their technical platforms against yet-unknown technology changes, and secure their systems against a constantly evolving threat environment. Rimini Street’s new solutions enable organizations to leverage their existing systems as a solid foundation for an innovative hybrid IT strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/

Novaliq to Present Scientific and Clinical Research During the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu, HI24.4.2018 15:53Pressemelding

Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced that four scientific posters will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Meeting in Honolulu, HI (April 29-May 3). The variety of data to be presented reflects Novaliq’s dedication to science and clinical research. With the collection of posters, Novaliq will share clinical and pre-clinical data on its EyeSol® drug delivery technology and provide insights into the mode of action of its NOV03/NovaTears® water-free therapy for the treatment of dry eye disease (DED). Furthermore, Novaliq will present its first pre-clinical efficacy data in glaucoma. Scientific posters supported by Novaliq will include: “Influence of perfluorohexyloctane containing eye drops on tear film thickness in patients with mild to moderate dry eye disease.” Authors: Garhöfer G., Schm

Temasys Communications and Appian Partner to Power Real-Time Communications in the Contact Center24.4.2018 15:00Pressemelding

Temasys Communications announced today that Appian has integrated with the Temasys Skylink technology, enabling real-time communications, including chat and co-browsing, in Appian’s new Intelligent Contact Center (ICC) Platform. “For our contact center customers, omni-channel communications are essential. Appian is working with Temasys to provide contact centers with real-time communication channels such as chat and co-browsing via the Temasys versatile SDKs,” said Arturo Oliver, Senior Director of Product Strategy at Appian. Temasys Skylink APIs will be compatible with the Appian Intelligent Contact Center Platform, making it easy for Appian customers to add real-time communication to their applications, including chat, voice, video and co-browsing. These integrations enable users to visit a website, begin a chat session that seamlessly escalates to a voice call and extend to co-browsing — all without changing apps or establishing a new connection. “We’re thrilled to work with Appian

PPG Reports Sustainability Progress, New 2025 Goals24.4.2018 13:07Pressemelding

PPG (NYSE:PPG) today released its 2017 Corporate Sustainability Report, which details the company’s continued progress in strengthening its sustainable operations in 2017 and the launch of new, aggressive sustainability goals it aims to achieve by 2025. The report is available at sustainability.ppg.com. “PPG’s sustainability efforts go beyond product innovations to extend to our customers’ operations and the communities in which we operate,” said Mark Cancilla, PPG vice president, environment, health and safety. “We are encouraged by our progress in 2017 and excited about our new goals, which are representative of the challenges and opportunities of our current business portfolio.” The company achieved the following progress in 2017: 32 percent of sales from products that provide customers with a sustainable advantage, an increase of 60 percent since 2012. This includes the unveiling of multiple products that provide a sustainable solution, such as Sigma Air Pure, a revolutionary bio-b

Bioiberica Approves Its Combined Drug for Osteoarthritis in Five More European Countries24.4.2018 12:17Pressemelding

Bioiberica's combination of chondroitin sulphate and glucosamine hydrochloride, a slow action drug to treat osteoarthritis symptoms, was approved as an ethical drug in France, Austria, Hungary, Poland, and Finland through a mutual recognition process from Spain. ‘This approval confirms that Drug Agencies from different countries attest to the effectiveness and safety of the combination of pharmaceutical grade chondroitin sulphate and glucosamine hydrochloride. This drug has proven to reduce pain and improve mobility in people affected by knee osteoarthritis which, due to its safety profile, could also be used as an alternative by those patients with cardiovascular or gastrointestinal problems who should not be prescribed anti-inflammatory drugs chronically’, stated Dr Juan Gispert, Bioiberica's R&D director. The principle study that guarantees its effectiveness is the MOVES clinical trial, published in the Annals of the Rheumatic Diseases, which concludes that the combination of chondr